FDA and EMA Expectations for Good Documentation Practices (GDP) in GMP and GCP Environments

Charles H. Paul
Instructor: Charles H. Paul
Date: Tuesday June 17, 2025
Time:

10:00 AM PDT | 01:00 PM EDT

Duration: 60 Minutes
Webinar Id: 606469

Price Details

Live Webinar
$150. One Attendee
$290. Unlimited Attendees
Recorded Webinar
$190. One Attendee
$390. Unlimited Attendees
Combo Offers   (Live + Recorded)
$289 $340   One Attendee
$599 $680   Unlimited Attendees

Unlimited Attendees: Any number of participants

Recorded Version: Unlimited viewing for 6 months (Access information will be emailed 24 hours after the completion of live webinar)

Overview:

Good Documentation Practices (GDP) are a critical requirement in both Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) environments, ensuring the accuracy, integrity, and reliability of records that support regulatory compliance.

This webinar will explore the FDA and EMA expectations for GDP, covering key regulatory frameworks, including FDA 21 CFR Parts 211, 820, 312, and 812, as well as EMA EudraLex Volume 4 and ICH E6 (R2). Participants will learn how to implement ALCOA+ principles, manage paper and electronic records, handle documentation errors, and ensure compliance in audits and inspections. Through practical examples and case studies, attendees will gain valuable insights into maintaining documentation integrity, reducing regulatory risks, and aligning with global standards for GMP and GCP.

Why you should Attend:

Accurate and compliant documentation is the backbone of regulatory success in GMP and GCP environments, and failure to meet FDA and EMA expectations can lead to serious compliance risks.

This webinar is essential for professionals in manufacturing, clinical research, quality assurance, and regulatory affairs who want to strengthen their understanding of Good Documentation Practices (GDP). Participants will learn how to apply ALCOA+ principles, manage paper and electronic records, and prevent common documentation pitfalls. Through expert insights and real-world case studies, this session will provide practical strategies to improve documentation integrity, streamline compliance efforts, and confidently prepare for regulatory inspections.

Areas Covered in the Session:

  • Introduction 
    • Welcome and Objectives
    • Importance of Good Documentation Practices (GDP)
    • Overview of Regulatory Authorities: FDA vs. EMA
    • Key Differences in GMP and GCP Documentation Requirements
  • Regulatory Framework and Expectations 
    • GMP Requirements for GDP
      • FDA 21 CFR Part 211 & 21 CFR Part 820
      • EMA EudraLex Volume 4 (Annex 11 & Annex 15)
    • GCP Requirements for GDP
      • FDA 21 CFR Part 312 & Part 812
      • EMA ICH E6 (R2) - Good Clinical Practice
    • Documentation Expectations: Accuracy, Legibility, Traceability, and Compliance
    • Common Documentation Deficiencies Identified in Inspections
  • Principles of Good Documentation Practices 
    • ALCOA+ Principles (Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available)
    • Handling Paper vs. Electronic Documentation
    • Requirements for Raw Data, Records, and Reports
    • Change Control and Version Control in Documentation
    • Documentation Integrity: Audit Trails, Data Security, and Retention
  • Documentation Best Practices in GMP and GCP 
    • Writing Clear, Concise, and Compliant SOPs, Protocols, and Reports
    • Review and Approval Processes: Roles and Responsibilities
    • Handling Corrections and Deviations in Documentation
    • Ensuring Consistency Between GMP Batch Records and GCP Study Records
  • Training Staff on GDP Compliance
    • Case Studies & Common Pitfalls 
    • Real-World Examples of GDP Non-Compliance and Its Consequences
    • Best Practices for Avoiding Regulatory Findings

Who Will Benefit:

  • Quality Assurance (QA) Manager
  • Quality Control (QC) Specialist
  • Regulatory Affairs Specialist
  • Compliance Officer
  • Clinical Research Associate (CRA)
  • Clinical Research Coordinator (CRC)
  • Clinical Quality Manager
  • Documentation Specialist
  • Manufacturing Supervisor
  • GMP Auditor
  • GCP Auditor
  • Validation Specialist
  • Process Engineer
  • Laboratory Manager
  • Pharmacovigilance Specialist
  • Medical Writer
  • R&D Scientist
  • Training Manager
  • Supplier Quality Manager
  • Operations Manager

Speaker Profile
Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, manufacturing, training, and technical documentation consulting firm – celebrating its twentieth year in business in 2017. Charles has been a regulatory and management consultant and an Instructional Technologist for 30 years and has published numerous white papers on various regulatory and training subjects. The firm works with both domestic and international clients designing solutions for complex training and documentation issues.

He has held senior positions in consulting and in corporate training development prior to forming C. H. Paul Consulting, Inc.. He also worked for several years in government contracting managing the development of significant Army-wide training development contracts impacting virtually all of the active Army and changing the training paradigm throughout the military.

He has dedicated his entire professional career explaining the benefits of performance-based training

Sign Up for Our Newsletter